Marti Technologies Inc. to Report 2023 First Half Results on October 13, 2023
Marti Technologies, Inc. ("Marti" or the "Company") (NYSE American: MRT), Türkiye's leading mobility super app, will announce 2023 First Half financial and operational results before the U.S. markets open on Friday, October 13, 2023.
Conference Call and Webcast Details
Marti's management will host an analyst and investor conference call and live webcast to discuss its financial results at 15.30 ?stanbul / 14.00 London / 8.30 a.m. New York time on Friday, October 13, 2023.
A replay will be available on the Marti Investor Relations website https://ir.marti.tech/ following the call.
Marti's results presentation will be available on Marti Investor Relations website https://ir.marti.tech/ on October 13, 2023.
About Marti Technologies, Inc.
Founded in 2018, Marti is Türkiye's leading mobility app, offering multiple transportation services to its riders. Marti operates a ride hailing marketplace service that matches riders with car and motorcycle drivers, and operates a large fleet of e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure. For more information visit www.marti.tech.
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...
